Early Day Notes: Mercury Systems (NASDAQ:MRCY), American Lorain Corporation (NYSEMKT:ALN), Agios Pharmaceuticals (NASDAQ:AGIO), Terreno Realty Corp. (NYSE:TRNO)


Exeter Resource Corporation (NYSEMKT:XRA) shares moved up 4.25% in last trading session and ended the day at $0.33. XRA has a return on assets of -33.20%. Exeter Resource Corporation (NYSEMKT:XRA) quarterly performance is -18.63%.

Exeter Resource Corporation (NYSEMKT:XRA)‘s stock had its “” rating reiterated by equities researchers at TD Securities in a report issued on Friday, Analyst Ratings.Net reports. They currently have a $0.85 target price on the stock, down from their prior target price of $1.00. TD Securities’ target price points to a potential upside of 63.46% from the stock’s current price.

Mercury Systems, Inc. (NASDAQ:MRCY) ended the last trading day at $19.66. Company weekly volatility is calculated as 1.64% and price to cash ratio as 8.64. Mercury Systems, Inc. (NASDAQ:MRCY) showed a weekly performance of 2.77%.

On 23 November, Mercury Systems, Inc. (NASDAQ:MRCY) announced that its Mercury Defense Systems (MDS) subsidiary was awarded a firm-fixed-price, indefinite delivery/indefinite quantity (IDIQ) time and material contract worth up to $41.8 million to deliver 200 advanced miniaturized Digital RF Memory modulators (Mini DRFM) to the U.S. Navy. The contract was received in the Company’s fiscal 2016 second quarter. Work will be performed at the Company’s Cypress, Calif. facility and is expected to be completed in November 2020.

On 27 November, American Lorain Corporation (NYSEMKT:ALN) shares advanced 2.70% and was closed at $1.14. ALN EPS growth in last 5 year was -27.50%. American Lorain Corporation (NYSEMKT:ALN) year to date (YTD) performance is 20.00%.

On 20 November, American Lorain Corporation (NYSEMKT:ALN) announced financial results for the third quarter ended September 30, 2015. Revenue decreased by $7.58 million to $47.68 million for the third quarter FY 2015 compared to the prior year period.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares advanced 0.77% in last trading session and ended the day at $69.05. AGIO has a return on assets of -22.00%. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) quarterly performance is -23.86%.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.

Terreno Realty Corp. (NYSE:TRNO) caters to the Financial space. It has a net profit margin of 12.70% and weekly performance is 1.56%. On the last day of trading company shares ended up at $23.38. Terreno Realty Corp. (NYSE:TRNO) distance from 50-day simple moving average (SMA50) is 9.08%.

On 23 November, Terreno Realty Corp. (NYSE:TRNO) acquired an industrial property located in Fairfield, New Jersey on November 20, 2015 for a purchase price of approximately $3.2 million. The property consists of one industrial building containing approximately 40,000 square feet on approximately 3.5 acres adjacent to I-80 and U.S. Route 46.


Leave a Reply

Your email address will not be published. Required fields are marked *